Saturday, September 4th, 2010 at
8:25 PM
A recently completed research evaluated insomnia symptoms and the extent to which they are associated with clinical and demographic patient characteristics, daytime symptoms, and functional performance in patients with stable heart failure (HF).
In a cross-sectional, observational research study with a setting as a five structured HF disease management programs in the Northeastern U.S.
This research study involved 173 stable chronic HF patients as participants.Full polysomnography was obtained for one night in participants’ homes. Read the rest of this entry
Thursday, July 15th, 2010 at
4:37 PM
Clinic-based observational studies in men have reported that obstructive sleep apnea is associated with an increased incidence of coronary heart disease. The objective of this study was to assess the relation of obstructive sleep apnea to incident coronary heart disease and heart failure in a general community sample of adult men and women.
A total of 1927 men and 2495 women
40 years of age and free of coronary heart disease and heart failure at the time of baseline polysomnography were followed up for a median of 8.7 years in this prospective longitudinal epidemiological study. Read the rest of this entry
Wednesday, July 7th, 2010 at
2:37 PM
Cardiac Concepts, Inc., a developer of medical devices to treat Heart Failure patients who experience breathing disturbances during sleep, announced today enrollment of the first European patients in a Pilot Clinical Trial.
The purpose of the Pilot Study is to understand the respiratory and cardiac benefits of the RespiCardia(TM) System when treating a breathing disorder known as Central Sleep Apnea (CSA) in Heart Failure patients. Prof. Piotr Ponikowski, Principal Investigator of the Pilot Clinical Trial at The Medical University/4th Military Hospital in Wroclaw, Poland, commented that the system was successfully implanted in 2 male patients, ages 57 and 68 years with ischemic cardiomyopathy and symptoms of moderate heart failure. Despite optimal medical management, both experienced severe sleep breathing disorders. The trial is a 40 patient study being conducted in a number of centers worldwide. Implants are expected to begin in the United States in the coming months. Read the rest of this entry